z-logo
open-access-imgOpen Access
Anaesthetic Experience with Cryotherapy for Treatment of Hepatic Malignancy
Author(s) -
David B. Goodie,
Matthew Horton,
Richard Morris,
Ladislav Nagy,
David L. Morris
Publication year - 1992
Publication title -
anaesthesia and intensive care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 62
eISSN - 1448-0271
pISSN - 0310-057X
DOI - 10.1177/0310057x9202000418
Subject(s) - medicine , cryotherapy , surgery , anesthesia , atelectasis , malignancy , cryosurgery , blood loss , lung
Hepatic cryotherapy is a relatively new technique, currently employed in the treatment of unresectable liver malignancy, which involves direct freezing of tumour deposits with liquid nitrogen. In a review of 26 patients undergoing this procedure, the anaesthetic considerations are defined. The total operation time ranged from 133 to 410 minutes. In spite of preventative measures, varying degrees of hypothermia occurred (range 33.7° C to 36.5° C), but no sequelae were encountered. Mean blood loss was 926 ml, and eleven patients required blood transfusion of between one and five units. There was a marked drop in platelet count associated with cryotherapy (mean fall of 123,000/mm 3 by the second postoperative day). Following the procedure, fever and basal pulmonary atelectasis were common, while hypoglycaemia and renal impairment occurred on single occasions. Six patients underwent postoperative mechanical ventilation. Despite this, the mean hospital stay was under seven days.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom